SCHEMBL8077429

SCHEMBL8077429

C=CCSc1nc(CC=C)c[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ HPGD P15428 5/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ RECQL P46063 1/20 0.37
▸ PKM P14618 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.31
▸ TSHR P16473 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ RAB9A P51151 3/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3681230 0.87 ALDH1A1 (0.32) ALDH1A1HPGDMEN1KMT2A
SCHEMBL11876056 0.76 MEN1 (0.42) ALDH1A1HPGDMEN1KMT2ARECQL
SCHEMBL1076387 0.71 — —
SCHEMBL9364601 0.70 KMT2A (0.38) ALDH1A1HPGDMEN1KMT2ARECQL
SCHEMBL6627174 0.70 HPGD (0.49) ALDH1A1HPGDMEN1KMT2ARECQL
SCHEMBL11285037 0.69 — —
SCHEMBL6673952 0.69 — —
SCHEMBL15543602 0.69 — —
SCHEMBL7487070 0.69 — —
Hydrochloric Acid SCHEMBL16649758 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019048-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS Merck Sharp Dohme (Italia) S.P.A. (IT) 2000-07-19 — — EP disclosed
WO-1999016437-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS MERCK SHARP DOHME (ITALIA) S.P.A. (IT) 1999-04-08 — — WO disclosed
Send feedback